Quince Therapeutics, Inc. (QNCX)
NASDAQ: QNCX · Real-Time Price · USD
32.41
+1.15 (3.68%)
At close: Aug 13, 2026, 4:00 PM EDT
32.50
+0.09 (0.28%)
After-hours: Aug 13, 2026, 7:34 PM EDT
Quince Therapeutics Employees
Quince Therapeutics had 38 employees as of December 31, 2025. The number of employees increased by 2 or 5.56% compared to the previous year.
Employees
38
Change (1Y)
2
Growth (1Y)
5.56%
Revenue / Employee
n/a
Profits / Employee
-$951,447
Market Cap
31.70M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 38 | 2 | 5.56% | 38 | 0 |
| Dec 31, 2024 | 36 | 4 | 12.50% | 36 | 0 |
| Dec 31, 2023 | 32 | 11 | 52.38% | 32 | 0 |
| Dec 31, 2022 | 21 | -34 | -61.82% | 21 | 0 |
| Dec 31, 2021 | 55 | 17 | 44.74% | 55 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| IGC Pharma | 70 |
| Kyntra Bio | 34 |
| Actinium Pharmaceuticals | 27 |
| Tevogen | 18 |
| Lantern Pharma | 16 |
| BriaCell Therapeutics | 16 |
| Genenta Science | 9 |
| NanoViricides | 7 |
QNCX News
- 8 days ago - Quince Therapeutics Registration statement: Registration filing - Filings
- 10 days ago - Quince Therapeutics management to meet with Oppenheimer - TheFly
- 13 days ago - Quince Therapeutics registers to sell 15.47M shares of common stock for holders - TheFly
- 13 days ago - Quince Therapeutics Registration statement: Registration filing - Filings
- 13 days ago - Quince Therapeutics Proxy statement: Proxy filing - Filings
- 15 days ago - Quince Therapeutics initiated with an Outperform at Oppenheimer - TheFly
- 6 weeks ago - Quince Therapeutics Appoints Recognized Leaders in Pulmonary Medicine to Scientific Advisory Board - GlobeNewsWire
- 6 weeks ago - Quince Therapeutics trading halted, news pending - TheFly